We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

WERFEN

Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App




Werfen and Thermo Fisher Enter Into Worldwide Distributor Agreement for Hemostasis Testing Workcell

By LabMedica International staff writers
Posted on 05 May 2023

Werfen (Barcelona, Spain) has entered into a new long-term, exclusive partnership agreement with Thermo Fisher Scientific (Waltham, MA, USA) to globally distribute the TCAutomation laboratory automation system, specifically tailored for hemostasis diagnostics. More...

This agreement, a follow-up to their exclusive contract signed in 2015, allows Werfen to continue offering HemoCell Specialized Lab Automation, which has the largest global installed base of hemostasis automation workcells.

HemoCell streamlines laboratory workflow by integrating all stages of testing. It comprises Werfen's ACL TOP Family 50 Series Hemostasis Testing Systems and HemoHub Intelligent Data Manager, paired with Thermo Fisher's TCAutomation system. This combination standardizes sample processing, ensuring consistent turnaround times for routine and urgent samples. This efficiency frees up laboratory staff, improving overall lab efficiency and quality of work. Ultimately, HemoCell contributes to improving the quality of care while minimizing costs.

The TCAutomation laboratory automation system is designed to provide truly efficient workflow for laboratories through its modularity, flexibility, and connectivity. It aids in managing escalating workloads and improving quality. By offering flexible and cost-effective solutions, it automates the most labor-intensive pre- and post-analytical tasks. Its open concept enables direct interfaces with a broad range of analyzers. The TCAutomation system can be easily expanded with additional modules, thereby helping laboratories adapt to future needs and requirements and boost efficiency, productivity, and safety.

"This significant continuation of our long-term distribution agreement is a testament to the strength of our partnership with Thermo Fisher Scientific," said Remo Tazzi, Vice President, Worldwide Marketing and Service, Hemostasis and Acute Care Diagnostics at Werfen. "It also speaks volumes about the success of HemoCell, and the quality of Werfen's workflow experts, their innovative tools and processes, and the value they offer hospital laboratories around the world."

Related Links:
Werfen 
Thermo Fisher Scientific 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Gel Cards
DG Gel Cards
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Cancerguard test is designed to help find multiple cancers in earlier stages to close gaps in cancer screening (Photo courtesy of Exact Sciences)

First-of-Its-Kind Blood Test Detects Over 50 Cancer Types

Many cancers lack routine screening, so patients are often diagnosed only after tumors grow and spread, when options are limited. A faster, less invasive approach that broadens early detection could shift... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.